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Administering a wrong drug or a wrong dose can be extremely dangerous and can result in severe
adverse effects or even the death of a patient. With human errors being possible, automatic real time
identiﬁcation of a drug and its concentration using technology is a viable option to decrease the chance
of incorrect drug administration. As a step toward this goal, we propose a new optical ﬁber based spec-
troscopic system that has built-in ﬁltration capabilities and thus can work in real time near patient with-
out additional sample pre-processing. It is designed as a point probe consisting of an optical ﬁber with a
miniature ﬁltering reﬂector integrated on the interface. In the future it can be inserted into a bag for
intravenous therapy (IV therapy) or in a syringe to measure the spectrum of the ﬂuid and to conﬁrm
its properties. Additionally, use of microﬂuidic ﬁltration allows to remove microscopic particles from
the sample and thus decreases the noise and increases the sensitivity of spectroscopic measurement.
In this study, an optoﬂuidic system was fabricated, and ﬁltration capabilities and measurement of cobal-
amin (vitamin B12) concentration have been demonstrated.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Institute of Medicine estimated that as many as 98,000
patients die each year due to preventable medical errors, making
this the sixth leading cause of death in the United States, and
claiming more lives than diabetes or Alzheimer disease [1].
Additionally, the expense of medical care necessitated because of
medical errors, lost income, and disability, results in a total cost
between $17 billion and $29 billion per year [1]. There are many
potential sources of error in patient care, such as medical prescrip-
tions, transcriptions, dispensing and administration of drugs, and
monitoring patient’s responses. However, among these, adminis-
tration errors account for approximately 32% of morbidity and
mortality cases in inpatient facilities [2]. Because of this, there is
a pressing need to detect drug identity and concentration during
administration, allowing for precise measurement of dosages,
and preventing errors in real time before adverse effects take place.
While monitoring of speciﬁc medications such as antidepres-
sants and anticoagulants are important for compliance and toxicity
checks [3], there are many other pharmaceuticals that when
wrongly administered will result in dangerous consequences [2].
Currently, several specialized assay based techniques have been
used to monitor medication errors in speciﬁc therapeutic
treatments, known as therapeutic drug monitoring (TDM) [3–6].However, assay and label based detection systems such as
immunoassays, electrochemical assays, and lateral-ﬂow assays
(LFAs) have several limitations that prevent them from being used
for point-of-care sensing [7]. These techniques are time consum-
ing, and require large volumes of analyte to achieve the needed
sensitivity. Furthermore, drug assays use complicated electro-
chemical measurements, suffer from background interference in
complex solutions and have poor thermal stability [8–14].
Currently there are no available technologies for detection of
overdose or incorrect drugs during administration.
There are many sensors that can work in almost real time and
do not require use of reagents, but they typically measure refrac-
tive index and are based on ring-resonators [23–26], photonic-
crystals [15–21], whispering gallery-mode [22–24], plasmonic
structures [25] and other optical components, that without addi-
tional modiﬁcations do not provide enough speciﬁcity for differen-
tiation between multiple drugs. In addition, these techniques are
prone to noise caused by any microscale particles present in the
system and are very sensitive to small temperature changes.
In general, traditional approaches to drug identiﬁcation include
color test [26], microscopic microcrystal analysis [27], thin layer
chromatography [28], gas chromatography [29], mass spectros-
copy [30], X-ray diffraction [31], and different types of spectros-
copy that are most suitable for real time detection. By using
traditional spectroscopic techniques (IR, Near-IR, NMR, Raman,
etc.) it has been shown that drug identity can be determined
[32–35]. Once a drug has been identiﬁed using traditional
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obtained by quantifying absorption at a speciﬁc wavelength. Fur-
thermore, spectroscopy using a single optical ﬁber is becoming a
powerful approach for analysis of biological samples [36–40].
However, for complex systems such as biological ﬂuids that
contain a variety of free ﬂoating particles and cells, the effective-
ness in determining a drugs concentration is signiﬁcantly reduced
due to scattering and interference by these objects. As a result,
additional reagents are required to amplify the spectral signatures
of compounds of interest (e.g. biomarkers of a speciﬁc multiple dis-
eases) [41–43]. Unfortunately, studies requiring reagents and
labeling can only be performed in specialized laboratories, using
large sample volumes, as well as extensive time for analysis rang-
ing from several hours to multiple days. Because of this, a reliable,
reagent and label-free, detection method that can run in real-time
by using a small sample volume would greatly beneﬁt point-of care
drug monitoring.
To overcome these limitations we have proposed a new opto-
ﬂuidic platform that can be used to detect the concentration of
drugs by absorption spectroscopy, free of noise from particles
and cells, without prior sample pre-processing. This device is small
enough that it can be directly inserted to an IV bag or syringe, and
continuously monitor drug concentration before or while the
patient is being treated. Additionally, this device can be mass-pro-
duced and requires relatively inexpensive materials.
2. Materials and methods
2.1. Device principles
The device was designed to be a compact probe, consisting of a
miniature microﬂuidic chamber attached to the interface of an
optical ﬁber (Fig. 1). The bottom of the microﬂuidic chamber con-
sists of a porous membrane that allows ﬂuids and chemical com-
pounds to ﬂow inside the device, while at the same time ﬁltering
out undesired particles. Furthermore, the porous membrane is
coated with a reﬂective metal. Because of this coating, light will
pass through the ﬁltered ﬂuid and reﬂect back once it reaches
the membrane. The reﬂected light can then be collected by the
optical ﬁber for spectroscopic analysis of the ﬁltered ﬂuid. Based
on the absorption of light by the ﬂuid, the system can provide a
conclusion if the drug dosage is correct. The top portion of the
chamber might also contain small pores to allow air to escape
while the chamber is being ﬁlled. Alternatively, if the top portion
of the chamber is not inserted in ﬂuid, then it might have larger
air outlets.Fig. 1. Artistic rendering of the design of the optoﬂuidic probe and its main
components: optical ﬁber with attached microﬂuidic chamber. Sample ﬂuid would
propagate through the micrometer-size pores while particles are ﬁltered out. The
bottommembrane is reﬂective, so light exiting the ﬁber into sample ﬂuid contained
in the chamber is coupled back into the same ﬁber for analysis.2.2. Fabrication ﬂow
The reﬂective micro-porous membrane for the ﬂuid chamber
was fabricated using standard micro-fabrication processes (Fig. 2)
[44,45]. Double-side polished silicon wafers purchased from Nova
Electronic Materials (Texas) were used as the substrate (Fig. 2a).
First, a 1 lm thick membrane layer of silicon nitride (Si3N4) was
grown on both side of the wafer by low stress–low pressure chem-
ical vapor deposition (LPCVD) at the MiRC facility at Georgia Tech
(Fig. 2b). Wafers were cleaned with acetone and IPA, then dried
with nitrogen. Additionally, they were bake on hotplate @ 115 C
for 5 min to dehydrate and then cooled for a couple of minutes
before spin-coating with photoresist.
Next, Si3N4 layer was patterned (Fig. 2c), deﬁning the transpar-
ent microﬁltering membrane on one side and optic ﬁber opening
on the other side. It was done by spin-coating positive photoresist
followed by UV lithography and reactive ion etching on both sides
of the wafer. Two consecutive photolithography steps required
through-wafer alignment using IR mask aligner. The recipe for
the photoresist deposition was the following: 4620AZ Positive
Resist was spin-coated ﬁrst at 4000 rpm for 30 s, then at 500 rpm
for 10 s and ﬁnally at 6500 rpm for 60 s. This allowed to achieve
the most uniform surface coverage. Then it was baked in oven at
100 C for 20 min and rehydrated for 24 h. The exposure was 7 s
on Karl Suss mask aligner (lamp intensity 25 mW/cm2). After that
it was developed for 3 min in photoresist 400 K developer, hard
baked at 100 C for 30 min and used for etching in RIE.
After patterning silicon nitride layers the exposed silicon was
etched away in a solution of potassium hydroxide (KOH, 85 C)
for 7 h, creating a hollow chamber between the two nitride layers.
This chamber will be ﬁlled with the ﬂuid under study through the
nitride membrane. Finally, 200 nm of gold was deposited on top of
the nitride membrane using a Denton Thermal Evaporator. An opti-
cal microscopy image of the micro-fabricated membrane is shown
in Fig. 2f. The circular pores of the membrane are 10 lm in diam-
eter, and have been patterned in a square array with the distance of
15 lm from center to center. This conﬁguration of the membrane
allows for ﬁltration of particles larger than 10 lm in diameter.
2.3. Filtration experiment
Once the membranes had been prepared, their ﬁltration capa-
bilities were tested. The membranes were pre-wetted and cleaned
by ﬂushing them with acetone while switching from sample toFig. 2. Device fabrication: (a) two-side polished silicon substrate. (b) Silicon nitride
is deposited on both sides of the wafer. (c) Silicon nitride was patterned and etched
on both sides. (d) The membrane was released using etching in KOH solution. (e)
Gold was deposited on the membrane. (f) Optical microscopy image of a released
membrane.
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optical microscope for observation, where the membrane surfaces
were oriented perpendicular to the microscope objective. They
were slightly elevated, allowing for space to exist beneath them.
In order to observe ﬁltration with these membranes, a droplet of
DI water containing naturally occurring contaminants (dust) was
placed on top of the membrane surface. By relying on gravitational
forces alone, the droplet of water was allowed to pass through the
membrane, while contaminants were effectively ﬁltered out. These
effects were recorded using a microscope camera. After the ﬁltra-
tion experiment was completed, the membranes were easily
cleaned by rinsing with acetone.
2.4. Optical experiments
2.4.1. Device packaging
After testing ﬁltering properties of the micro-ﬁltering mem-
branes they were assembled next to the optical ﬁber tips. For this,
an 8 lm optical ﬁber was cleaved and inserted into an adjustable
ﬁber holder (Fig. 3a) to provide mechanical support to the other-
wise ﬂexible ﬁber. The enlarged image of the exposed ﬁber tip is
shown in Fig. 3b. Following this, the ﬁber holder was inserted into
a high precision XYZ-stage, and the tip was positioned 105 lm
from a reﬂective metal membrane by adjusting the dial of the opti-
cal stage (Fig. 3c). For optical alignment procedures, please refer to
the following Section (2.4.2). In Fig. 3d, an enlarged image of the
ﬁber tip and membrane in the assembly is shown. It may be seen
that spacing (105 lm) exists between the ﬁber and the mem-
brane, and that the membrane itself is coated with gold. Finally,
the entire device was ﬁxed in place by epoxying the metal sur-
rounding the membranes to a small polydimethylsiloxane (PDMS)
tube. This tube was created to ﬁt tightly to the optical ﬁber holder,
and the ﬁnal assembly can be seen in Fig. 3e.
2.4.2. Fiber alignment and positioning
As previously stated, before the setup was ﬁxed in place the
optical ﬁber and membrane required alignment and positioning
at an appropriate spacing. In order to optimize coupling, the optical
ﬁber was set perpendicular to the membrane. Angular alignment of
the system was performed by adjusting the XYZ-stage, and observ-
ing the reﬂected power in air. An approximation of ﬁber angle wasFig. 3. Details of the packaging. (a) Cleaved optical ﬁber inserted into ﬁber holder, (b) enl
precision XYZ-stage. (d) Optical ﬁber above reﬂective gold coated membrane. (e) Fully
ﬁltering membrane connected at the bottom.made qualitatively through visual observation. However, for added
precision, reﬂected power was recorded while the ﬁber angle was
ﬁnely tuned. The ﬁber angle was set once the reﬂected power reach
a maximum value.
Following angular alignment, the ﬁber needed to be placed at a
set spacing from the membrane surface. The XYZ-stage allows for
vertical adjustment of the ﬁber. However, micron level precision
was needed to effectively determine the spacing, and thus Fabry–
Perot resonance was used for high precision measurements. The
resonance was formed between the two reﬂective surfaces – the
gold coated membrane and the cleaved ﬁber interface. The spec-
trum was recorded in air (refractive index: 1.0) and conducted
using infrared light between 1400 and 1500 nm (shown in Fig. 4
for the desired spacing). Using the collected IR spectrum, the dis-
tance could be calculated using the following expression:
d ¼ ki
2
2nðkiþ1  kiÞ ð1Þ
where ki and ki+1 are consecutive resonance wavelengths (nm), n is
the refractive index. By recording resonance patterns for different
vertical settings of the XYZ-stage, a correlation between stage set-
ting and the actual distance, determined by Eq. (1), was obtained.
Once the appropriate vertical setting was found, the ﬁber was ﬁxed
in position and the distance was veriﬁed again using Fabry–Perot
resonance. In Fig. 4, we can see the Fabry–Perot resonance recorded
for the vertical setting once the ﬁber was set 105 lm from the
membrane.2.4.3. Absorption spectroscopy of Cobalamin
In order to demonstrate that the device is capable of determin-
ing drug and its concentrations, absorption spectroscopy was con-
ducted for a speciﬁc pharmaceutical – cobalamin (vitamin B12).
Different drugs can be identiﬁed using UV–vis spectroscopy. For
example, absorption spectrum of cobalamin dissolved in water
with concentration 60 mg/dL is shown in Fig. 5a. When drug is
known, its concentration can be measured at one speciﬁc wave-
length, since it is much faster than measurements of the whole
spectrum.
The goal was to construct a sensor that would be able to con-
duct measurements for the broad range of concentrations fromarged tip of the ﬁber that is 125 lm in diameter. (c) Optical ﬁber holder ﬁxed in high
assembled device with an optical ﬁber enclosed inside of the ﬂuid chamber and a
Fig. 4. Fabry–Perot resonance of the set-up used in this experiment. Here the
resonance corresponds to a separation of approximately 105 lm between the ﬁber
and reﬂector.
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transfer function was conducted using Beer–Lambert law:
P
Po
¼ expð2adCÞ ð2Þ
where P is the power of transmitted light (W) for the ﬂuid under
study, Po is the transmitted power (W) for a pure sample, a is the
molar absorptivity with units of L/mol cm, 2 d is the total optical
path where d was the spacing between the ﬁber and reﬂective sur-
face (cm), and C is the concentration of the cobalamin expressed in
mol/L.
Fig. 5 shows the theoretical transfer functions plotted for the
needed range of concentrations and three different spacing
between the ﬁber and the membrane – 75, 105 and 150 lm. While
150 lm gap is better for the measurements of lower concentra-
tions, and 75 lm works better for higher concentrations, the
105 lm gap is suitable for both ranges and thus was chosen for
the experimental testing.
During the experiment, the concentration of cobalamin was
varied from approximately 0.1–515 mg/dL, while reﬂected power
was recorded for each concentration. All measurements were con-
ducted over 5 min timeframes, during which the power was aver-
aged. A high stability green laser (532 nm) was used at a ﬁxed
power at 30 mW. After one cobalamin measurement was made,
the sample was removed, and the sensor was thoroughly rinsed
with water. This cleaning was conducted to prevent build-up of
cobalamin on surfaces. After cleaning, the setup was allowed to
air dry for approximately 1 min, ensuring that all water was
removed from the system. Samples were tested sequentially with
increasing concentration. In order to insure reproducibility of
results, every test was calibrated with respect to the water control
measurements.Fig. 5. Experimental absorption spectrum (a) and theoretical transmission3. Results and discussion
3.1. Filtration demonstration
As previously mentioned, the ﬁltering properties of the micro-
fabricated porous membrane were demonstrated with a drop of
DI water. Fig. 6a and b show the empty membrane placed horizon-
tally under the microscope and a membrane right after putting a
drop of water, respectively. It may be noticed that the water passes
through the pores in the membrane, and forms a drop on the other
side, while all particles are ﬁltered by the pores and remain on the
membrane surface (Fig. 6b–f). Fig. 6f demonstrates the outline of
the water drop that is not fully seen since it is already under the
membrane, and the dark spots are particles that are present in
all real world samples and were successfully ﬁltered out by the
membrane.
For cleaning purposes the membrane was ﬂushed with acetone.
It was observed that this also improved its wetting properties.
While without applying additional pressure, water goes takes sev-
eral minutes to completely pass through the membrane. However,
prior prewashing decreases this time to seconds (Fig. 6g–i). The
membrane was also tested continuously with the lowest setting
of a peristaltic pump pumping ﬂuid with the ﬂow rate 2 lL/s,
and it could withstand the external pressure still demonstrating
successful particle ﬁltration.3.2. Optical measurement of cobalamin concentrations
While the proposed optoﬂuidic platform is compatible with a
broad range of drugs, here we demonstrated measurements of
cobalamin concentration as an example drug that can be moni-
tored using this approach. Cobalamin (vitamin B12) is an essential
water-soluble vitamin, of which a deﬁciency can lead to abnormal
neurologic and psychiatric symptoms. This may include ataxia
(shaky movements and unsteady gait), muscle weakness, spastic-
ity, incontinence, hypotension (low blood pressure), vision prob-
lems, dementia, psychoses, and mood disturbances. There is a
variety of doses that are used for injections: from 0.2 lg/kg for
neonates and infants to 1000 lg total for adults with severe vita-
min deﬁciency [46]. This means range of concentrations from
1 lg/ml to 1000 lg/ml, therefore the Fig. 7b shows measurements
of concentrations between 1 lg /mL to 5 mg/mL to monitor the
physiological range and potential overdose.
Because cobalamin was the only compound sensed, all the mea-
surements were conducted with a single wavelength, 532 nm,
where cobalamin has high absorption and the sensor would have
the highest sensitivity. In future sensing at multiple wavelengths
can be used to monitor mixture of several drugs simultaneously.proﬁles for Cobalamin (b) at varying concentrations and ﬁber spacing.
Fig. 6. Demonstration of successful ﬁltration using microﬂuidic membrane – while water goes through the membrane for further analysis, all the contamination stays on the
surface.
Fig. 7. (a) Samples of different concentrations of cobalamin arranged in order of decreasing concentration. (b) Corresponding experimental results of optical measurements of
cobalamin concentration.
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ment in order of decreasing concentration (left to right). As a
results, the experimental points are well ﬁtted by the theoretical
curve obtained using Beer–Lambert Law (R2 = 0.994).4. Conclusion
In conclusion, we presented a new optoﬂuidic platform for
near-patient drug monitoring designed with the purpose of provid-
ing additional level of safety for drug administration and decreased
human error. This has the potential of reducing preventable deaths
due to medical errors. By combining spectroscopic analysis withmicroﬂuidic ﬁltration, the system allows rapid and accurate testing
for drug concentrations levels. Design, optimization, fabrication
and experimental testing of this system for the measurement of
cobalamin concentration demonstrated that this approach is
promising. Furthermore, it opens up a whole area of optoﬂuidic
ﬁber based drug monitoring where future work includes analysis
of multiple drugs and their mixtures and integration with syringes
and IV-bags.Conﬂict of interest
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